Farnesyl Transferase Antibodies

Santa Cruz Biotechnology features a diverse variety of Farnesyl Transferase monoclonal antibodies for research applications in cellular processes. Farnesyl Transferase monoclonal antibodies are suitable for multiple experimental techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Farnesyl transferase is an essential enzyme involved in the post-translational modification of proteins, specifically in the farnesylation process, which is crucial for the proper localization and function of many signaling proteins. The farnesylation modification plays a significant role in cell growth, differentiation, and survival, making farnesyl transferase a key player in various diseases, including cancer. Understanding farnesyl transferase function can provide insights into therapeutic targets and potential interventions. Farnesyl transferase research has revealed important mechanisms in cellular signaling pathways and protein regulation. Investigating farnesyl transferase activity has led to discoveries in cancer biology and potential treatment strategies. Current research continues to uncover new roles for farnesyl transferase in cellular processes and disease development. Santa Cruz Biotechnology monoclonal antibodies for farnesyl transferase support researchers worldwide in advancing scientific understanding of cellular signaling and disease mechanisms.